Trial Profile
Randomized Phase II Trial Evaluating the Efficiency of Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Angiodysplasia
- Focus Therapeutic Use
- 10 Dec 2015 New trial record